BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17508172)

  • 41. Linkage analysis and functional evaluation of inherited clinical pain conditions.
    Krupp JJ; Hellgren D; Eriksson AB
    Methods Mol Biol; 2010; 617():309-25. PubMed ID: 20336431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pain, analgesia and genetics.
    Muralidharan A; Smith MT
    J Pharm Pharmacol; 2011 Nov; 63(11):1387-400. PubMed ID: 21988420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Migraine: a genetic disease?
    Montagna P
    Neurol Sci; 2008 May; 29 Suppl 1():S47-51. PubMed ID: 18545896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathways to the best fit of triptans for migraine patients.
    Buzzi MG
    Cephalalgia; 2008 Sep; 28 Suppl 2():21-7. PubMed ID: 18715329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacogenetics of headache treatment.
    Montagna P; Pierangeli G; Cevoli S; Mochi M; Cortelli P
    Neurol Sci; 2005 May; 26 Suppl 2():s143-7. PubMed ID: 15926014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FHM3 in familial hemiplegic migraine is more resistant to mutation than FHM1 and FHM2.
    Wiwanitkit V
    J Neurol Sci; 2009 Feb; 277(1-2):76-9. PubMed ID: 19007941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CNVs of human genes and their implication in pharmacogenetics.
    Johansson I; Ingelman-Sundberg M
    Cytogenet Genome Res; 2008; 123(1-4):195-204. PubMed ID: 19287156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Personalized therapy in pain management: where do we stand?
    Stamer UM; Zhang L; Stüber F
    Pharmacogenomics; 2010 Jun; 11(6):843-64. PubMed ID: 20504256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical genetics of functionally mild non-coding GTP cyclohydrolase 1 (GCH1) polymorphisms modulating pain and cardiovascular risk.
    Doehring A; Antoniades C; Channon KM; Tegeder I; Lötsch J
    Mutat Res; 2008; 659(3):195-201. PubMed ID: 18515178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphic cytochrome P450 enzymes and post-marketing drug dosage revisions: clinical relevance to dermatologic therapies.
    Saggar S; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(3):171-80. PubMed ID: 17687682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pain and genetics.
    Fernandez Robles CR; Degnan M; Candiotti KA
    Curr Opin Anaesthesiol; 2012 Aug; 25(4):444-9. PubMed ID: 22732422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations.
    Vahedi K; Depienne C; Le Fort D; Riant F; Chaine P; Trouillard O; Gaudric A; Morris MA; Leguern E; Tournier-Lasserve E; Bousser MG
    Neurology; 2009 Mar; 72(13):1178-83. PubMed ID: 19332696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacogenomics and therapeutic strategies for dementia.
    Cacabelos R
    Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Migraine genetics.
    Montagna P
    Expert Rev Neurother; 2008 Sep; 8(9):1321-30. PubMed ID: 18759544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Implication of genetic polymorphism on neuropathic pain].
    Iseki M; Sato-Takeda M
    Masui; 2009 Sep; 58(9):1112-21. PubMed ID: 19764434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines.
    Saper JR; Lake AE
    Headache; 2008 Jun; 48(6):838-49. PubMed ID: 18549361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The genetics of chronic headaches.
    Montagna P; Cevoli S; Marzocchi N; Pierangeli G; Pini LA; Cortelli P; Mochi M
    Neurol Sci; 2003 May; 24 Suppl 2():S51-6. PubMed ID: 12811592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved.
    Comelli F; Giagnoni G; Bettoni I; Colleoni M; Costa B
    Phytother Res; 2008 Aug; 22(8):1017-24. PubMed ID: 18618522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Migraine prevention.
    Dodick DW; Silberstein SD
    Pract Neurol; 2007 Nov; 7(6):383-93. PubMed ID: 18024778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First mutation in the voltage-gated Nav1.1 subunit gene SCN1A with co-occurring familial hemiplegic migraine and epilepsy.
    Castro MJ; Stam AH; Lemos C; de Vries B; Vanmolkot KR; Barros J; Terwindt GM; Frants RR; Sequeiros J; Ferrari MD; Pereira-Monteiro JM; van den Maagdenberg AM
    Cephalalgia; 2009 Mar; 29(3):308-13. PubMed ID: 19220312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.